Alzheimer's patients have abnormal haemoglobin in the brain. Changes in haemoglobin production may be key to understanding why excess amyloid-beta is toxic to brain cells. An insufficiency of haemoglobin, or an excess of amyloid-beta, creates a toxic 'lump' that cells cannot cope with or eliminate.